One-year follow-up study of Helicobacter pylori eradication rate with 13C-urea breath test after 3-d and 7-d rabeprazole-based triple therapy

Table 1 Demographic data of patients who underwent triple therapy.

	3-d group	7-d group
Patients (M/F)	36/22	37/201
Age (yr)	48.3 ±12.4	48.7±15.42
Peptic ulcers3
Gastric ulcers	9	12
Duodenal ulcers	40	38
Both	9	7

¹P = 0.75 (χ² test);

²P = 0.99 (two-sample t-test);

³P = 0.70 (χ² test).

Table 2 Eradication rate of patients who underwent triple therapy.

	3-d group	7-d group	P	OR (interval)
Ulcer healing rate
Patients number	58	57
ITT	47 (81.0%)	43 (75.4%)	0.47	0.72 (0.30-1.75)
PP	47 (90.4%)	43 (89.6%)	0.89	0.92 (0.25-3.38)
Eradication rate 3 mo after therapy
Patients number	58	57
ITT	44 (75.9%)	42 (73.7%)	0.79	0.89 (0.3-2.07)
PP	44 (84.6%)	42 (87.5%)	0.68	1.27 (0.41-3.98)
One year after therapy
Patients (M/F)	37 (23/14)	38 (24/14)	0.931	1.22 (0.39-3.80)
PP	29 (78.4%)	31 (81.6%)	0.73	0.82 (0.26-2.54)

ITT, Intention-to-treat analysis; PP, Per-protocol analysis,

¹P = 0.93 (χ² test).